標題: Titlebook: Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach; Nima Rezaei Book 2024 The Editor(s) (if applicable) [打印本頁] 作者: ISSUE 時間: 2025-3-21 16:56
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach影響因子(影響力)
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach影響因子(影響力)學科排名
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach網(wǎng)絡公開度
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach網(wǎng)絡公開度學科排名
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach被引頻次
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach被引頻次學科排名
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach年度引用
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach年度引用學科排名
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach讀者反饋
書目名稱Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach讀者反饋學科排名
作者: Strength 時間: 2025-3-21 22:41 作者: 小畫像 時間: 2025-3-22 01:29
https://doi.org/10.1007/978-3-531-90796-3studies, due to the properties of these molecules. Thus, this chapter will bring together studies that address the siRNA carried in the main types of drug delivery nanosystems for the treatment of breast cancer.作者: Palatial 時間: 2025-3-22 07:03 作者: granite 時間: 2025-3-22 11:23 作者: 驚呼 時間: 2025-3-22 16:25 作者: cipher 時間: 2025-3-22 18:05
Nima RezaeiDescribes interdisciplinary approaches on genetics of breast cancer.Includes a comprehensive coverage of immunological mechanisms of breast cancer.Contains updated reviews on breast cancer immunothera作者: Mirage 時間: 2025-3-22 21:40 作者: enumaerate 時間: 2025-3-23 05:01
https://doi.org/10.1007/978-3-531-19969-6 regulate pathways involved in cancer initiation and progression. Recently, the expression patterns of miRNAs have been used as biomarkers in diagnosing various cancers including breast cancer. MiRNAs are highly stable and can be found in various human samples including blood, serum, urine, and tiss作者: 無目標 時間: 2025-3-23 06:26
https://doi.org/10.1007/978-3-531-19969-6the limitations and side effects of conventional treatments, such as chemotherapy, surgery, and radiation therapy. Abnormal or malignant cells are quickly identified and destroyed by the immune system. However, cancer cells can hide from the immune system and avoid being attacked. Immunotherapy appe作者: 愛得痛了 時間: 2025-3-23 09:56
https://doi.org/10.1007/978-3-531-90796-3 have improved due to advancements in diagnostic and treatment modalities, with noninvasive breast cancer showing 90% and 84% survival rates at 5 and 10?years, respectively. Risk factors for breast cancer include genetic alterations, lifestyle factors, and hormonal influences. Classification of brea作者: 使顯得不重要 時間: 2025-3-23 15:42 作者: 肉體 時間: 2025-3-23 20:20 作者: obtuse 時間: 2025-3-24 01:47 作者: Erythropoietin 時間: 2025-3-24 03:12 作者: 逃避系列單詞 時間: 2025-3-24 09:30 作者: LAVE 時間: 2025-3-24 13:32
https://doi.org/10.1007/978-3-531-90796-3agents, including inhibitors targeting CDK4/6, PARP, and immune checkpoint molecules, have been clinically developed as molecular targeted therapy in the treatment of BC. However, these treatments are applicable to a limited type of BC, and are effective in only a small proportion of the treated pat作者: neutrophils 時間: 2025-3-24 18:23
https://doi.org/10.1007/978-3-531-90796-3ene silencing directed against the mRNA strand that prevents protein synthesis and enables the formulation of drugs with greater effectiveness and directionality to the therapeutic target and less side effect. However, these molecules have low stability and need the aid of delivery systems, so they 作者: Debate 時間: 2025-3-24 22:35 作者: 憤世嫉俗者 時間: 2025-3-25 01:17 作者: Amnesty 時間: 2025-3-25 07:24 作者: Bereavement 時間: 2025-3-25 08:20 作者: EVICT 時間: 2025-3-25 15:19
https://doi.org/10.1007/978-3-031-65808-2Breast cancer; Cancer prognosis; Immunotherapy; Cancer genetics; Virotherapy; Immunology; Cancer diagnosis作者: defeatist 時間: 2025-3-25 19:43
978-3-031-65810-5The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 教義 時間: 2025-3-25 23:22
Role of miRNAs in Triple-Negative Breast Cancer: Diagnosis, Prognosis, and Treatment, regulate pathways involved in cancer initiation and progression. Recently, the expression patterns of miRNAs have been used as biomarkers in diagnosing various cancers including breast cancer. MiRNAs are highly stable and can be found in various human samples including blood, serum, urine, and tiss作者: laparoscopy 時間: 2025-3-26 02:45
Approaches to Breast Cancer Immunology and Immunotherapy,the limitations and side effects of conventional treatments, such as chemotherapy, surgery, and radiation therapy. Abnormal or malignant cells are quickly identified and destroyed by the immune system. However, cancer cells can hide from the immune system and avoid being attacked. Immunotherapy appe作者: 扔掉掐死你 時間: 2025-3-26 07:05
Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches, have improved due to advancements in diagnostic and treatment modalities, with noninvasive breast cancer showing 90% and 84% survival rates at 5 and 10?years, respectively. Risk factors for breast cancer include genetic alterations, lifestyle factors, and hormonal influences. Classification of brea作者: Expiration 時間: 2025-3-26 11:48
Interleukins in the Development and Progression of Breast Cancer,approaches, breast cancer still holds the top position in cancer-associated deaths in women. Over the last few decades, researchers have been trying to reveal the exact etiology of this malignancy, for example, revealing molecular mechanisms behind this. Inflammation is a critical factor leading to 作者: 運氣 時間: 2025-3-26 13:54 作者: figment 時間: 2025-3-26 19:42 作者: surmount 時間: 2025-3-26 22:26 作者: aplomb 時間: 2025-3-27 03:42
Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer A has approved immunotherapy Keytruda in combination with chemotherapy for irresectable metastatic triple-negative breast cancer (TNBC) in 2020. Recent developments in different immunotherapy modalities have shown promise in breast cancer treatment to reduce mortality. Further, multifunctional nanop作者: 鋼筆尖 時間: 2025-3-27 06:48 作者: 一個姐姐 時間: 2025-3-27 10:00
siRNA Loaded in Drug Delivery Nanosystems as a Strategy for Breast Cancer Treatment,ene silencing directed against the mRNA strand that prevents protein synthesis and enables the formulation of drugs with greater effectiveness and directionality to the therapeutic target and less side effect. However, these molecules have low stability and need the aid of delivery systems, so they 作者: Mendacious 時間: 2025-3-27 14:21
Nucleic Acid and Drug Dual Agent Nanoplatforms for Breast Cancer,focused on improving the efficacy of existing drugs with the aid of nanoparticles. Other options are presented through gene therapy in which nucleic acids function as therapeutic agents. This too is reliant upon nanostructures for faithful introduction into tumor cells. Studies have shown that simul作者: 飛鏢 時間: 2025-3-27 20:24 作者: 鑲嵌細工 時間: 2025-3-28 00:43 作者: maintenance 時間: 2025-3-28 03:25
Book 2024st cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interd作者: single 時間: 2025-3-28 09:31 作者: Nomadic 時間: 2025-3-28 13:43
Approaches to Breast Cancer Immunology and Immunotherapy,mmune function and cancer development. Scientists are interested in understanding how the microbiome, immune system, and breast cancer cells interact in order to develop new prevention and therapeutic strategies for the disease. Utilizing the immune system to fight breast cancer is a promising new r作者: 完全 時間: 2025-3-28 15:01
Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches, and polygenic risk scores are essential for identifying target genes and predicting risk. Current treatments for breast cancer include chemotherapy, targeted therapy, and immunotherapies, with ongoing research focusing on improving long-term benefits for patients.作者: thwart 時間: 2025-3-28 21:10
Interleukins in the Development and Progression of Breast Cancer,re associated with acute inflammatory processes, including IL-8 and IL-12, whereas some with chronic inflammatory responses include IL-2, IL-3, IL-6, IL-10, IL-12, and others. Moreover, chronic inflammation leads to different signaling mechanisms and transcription factors and alters both the patient作者: DALLY 時間: 2025-3-29 00:35 作者: 骨 時間: 2025-3-29 07:04 作者: Spinous-Process 時間: 2025-3-29 08:57 作者: 消息靈通 時間: 2025-3-29 14:07 作者: 休閑 時間: 2025-3-29 18:49 作者: 防御 時間: 2025-3-29 19:52
Oncolytic Virotherapy Against Breast Cancer,apeutic agents for synergistic effects. The efficacy of oncolytic viruses has been substantiated through numerous preclinical investigations and more recently in human trials. Notably, the US Food and Drug Administration has granted approval for the utilization of talimogene laherparepvec, an oncoly作者: Cerumen 時間: 2025-3-30 00:15 作者: Proclaim 時間: 2025-3-30 06:11 作者: allergy 時間: 2025-3-30 12:12
